Earli, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Earli, Inc. - overview
Established
2018
Location
Redwood City, CA, US
Primary Industry
Biotechnology
About
Based in California, US, and founded in 2018 by Chief Executive Officer Cyriac Roeding, co-founder Sam Gambhir and Chief Scientist Officer David Suhy, Earli, Inc. operates as a developer of cancer treatment devices used to detect biomarkers in blood, urine, or breath for early treatment of cancer. In October 2024, Earli, Inc. raised an undisclosed amount in venture funding from new investor GLIN Impact Capital.
Earli, Inc. developed a platform known as the synthetic biopsy platform, which is a transformative approach to cancer diagnostics. The company’s technology prompts cancer cells to produce synthetic biomarkers, which can be detected via imaging technologies such as PET scans. In addition, the firm’s platform aids in early cancer detection but also has therapeutic applications by activating the immune system to target and destroy cancer cells.
It offers a synthetic biopsy approach that enhances the sensitivity and specificity of cancer detection for an earlier diagnosis, allowing pharmaceutical and biotech companies to create personalized treatments. The company plans to use the October 2024 funding for future expansion and improving survival rates and side effects for cancer patients.
Current Investors
Menlo Ventures, Andreessen Horowitz, ZhenFund
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Oncology/Cancer Treatment, Therapeutic Devices
Website
www.earli.com
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.